image image image image image
HHV-6A reactivation in a ciHHV-6A transplant patient with encephalitis Experts emphasize need for larger studies to determine the impact of ciHHV-6 on patient outcomes
Read the Full Story
Can a novel free radical scavenger help patients with HHV-6 encephalopathy? Patients with HHV-6 induced encephalopathy or AESD suffer from severe oxidative stress. Edaravone shows promise for reducing oxidation and neuronal damage in a condition that leaves 70% with permanent disability.
Read the Full Story
New findings characterize immune response to HHV-6 New details regarding the recognition and presentation of HHV-6 proteins by the immune system emerge and may help advance the field of HHV-6 immunotherapy.
Read the Full Story
HHV-6 antibody level correlates with relapse and progression in MS patients Anti-HHV-6 IgG titer may be a useful prognostic factor in predicting relapsing-remitting MS clinical course
Read the Full Story
HHV-6 reactivation predicts graft failure in cord blood transplant patients HHV-6 reactivation before engraftment strongly predictive of graft failure
Read the Full Story
1 2 3 4 5

Featured News

  • 1
  • 2
  • 3

Latest HHV-6 Research

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8

Repository of Reagents

Reagents for conducting HHV-6 & 7 research are available through the HHV-6 Foundation Repository

Learn More

About the Foundation

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B. The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since the HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge. Read More

ciHHV-6 Patient Registry

Except for transplant patients, HHV-6 plasma DNA tests are rarely positive. Any patient testing positive should rule out chromosomally integrated HHV-6, a condition that may be associated with increased HHV-6 reactivation.

Join now

Website development by inStyle Technologies